Targeted therapy in melanoma

por Tawbi, Hussein, Nimmagadda, Neelima
Publicado 2009

Melanoma Brain Metastases: An Unmet Challenge in the Era of Active Therapy

por Gorantla, Vikram, Kirkwood, John M., Tawbi, Hussein A.
Publicado 2013

Melanoma brain metastases: current areas of investigation and future directions

por Oliva, Isabella Glitza, Tawbi, Hussein, Davies, Michael A.
Publicado en Cancer J (2017)

55. A RANDOMIZED, MULTICENTER PHASE III TRIAL OF SURGERY PLUS STEREOTACTIC RADIOSURGERY (SRS) COMPARED WITH SURGERY PLUS PERMANENTLY IMPLANTED COLLAGEN TILE BRACHYTHERAPY (CTBT) FO...

por Weinberg, Jeffrey, McAleer, Mary Frances, Tawbi, Hussein, Lang, Frederick
Publicado en Neurooncol Adv (2020)

Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective

por Kasi, Pashtoon M, Tawbi, Hussein A, Oddis, Chester V, Kulkarni, Hrishikesh S
Publicado 2012

Safe and effective administration of T-VEC in a patient with heart transplantation and recurrent locally advanced melanoma

por Schvartsman, Gustavo, Perez, Kristen, Flynn, Jill E., Myers, Jeffrey N., Tawbi, Hussein
Publicado en J Immunother Cancer (2017)

CD8+ T cell responses in metastatic melanoma patients receiving an adenovirally antigen engineered dendritic cell vaccine +/- IFN-α

por Du, Samuel, Santos, Patricia M, Tawbi, Hussein, Tarhini, Ahmad, Kirkwood, John M, Butterfield, Lisa H
Publicado en J Immunother Cancer (2015)

Quantitation of paclitaxel, and its 6-alpha-OH and 3-para-OH metabolites in human plasma by LC-MS/MS

por Christner, Susan M., Parise, Robert A., Ivy, Percy S., Tawbi, Hussein, Chu, Edward, Beumer, Jan H.
Publicado en J Pharm Biomed Anal (2019)

Development of Immunotherapy Combination Strategies in Cancer

por Yap, Timothy A., Parkes, Eileen E., Peng, Weiyi, Moyers, Justin T., Curran, Michael A., Tawbi, Hussein A.
Publicado en Cancer Discov (2021)

A quasi-quantitative dual multiplexed immunoblot method to simultaneously analyze ATM and H2AX Phosphorylation in human peripheral blood mononuclear cells

por Bakkenist, Christopher J., Czambel, R. Kenneth, Hershberger, Pamela A., Tawbi, Hussein, Beumer, Jan H., Schmitz, John C.
Publicado en Oncoscience (2015)

High-dose interleukin-2 (HD IL-2) for advanced melanoma: a single center experience from the University of Pittsburgh Cancer Institute

por Davar, Diwakar, Ding, Fei, Saul, Melissa, Sander, Cindy, Tarhini, Ahmad A., Kirkwood, John M., Tawbi, Hussein A.
Publicado en J Immunother Cancer (2017)

Targeted Therapy and Immunotherapy Response Assessment with F-18 Fluorothymidine Positron-Emission Tomography/Magnetic Resonance Imaging in Melanoma Brain Metastasis: A Pilot Study

por Nguyen, Nghi C., Yee, Melissa K., Tuchayi, Abuzar M., Kirkwood, John M., Tawbi, Hussein, Mountz, James M.
Publicado en Front Oncol (2018)

Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma

por Lowe, Devin B, Bose, Anamika, Taylor, Jennifer L, Tawbi, Hussein, Lin, Yan, Kirkwood, John M, Storkus, Walter J
Publicado 2014

Effect of Renal Dysfunction on Toxicity in Three Decades of Cancer Therapy Evaluation Program–Sponsored Single-Agent Phase I Studies

por Beumer, Jan H., Ding, Fei, Tawbi, Hussein, Lin, Yan, Viluh, Diana, Chatterjee, Indrani, Rinker, Matthew, Chow, Selina L., Ivy, S. Percy
Publicado en J Clin Oncol (2016)

Safety and Efficacy of Combination Immunotherapy With Interferon Alfa-2b and Tremelimumab in Patients With Stage IV Melanoma

por Tarhini, Ahmad A., Cherian, John, Moschos, Stergios J., Tawbi, Hussein A., Shuai, Yongli, Gooding, William E., Sander, Cindy, Kirkwood, John M.
Publicado 2012

LC-MS/MS assay for the quantitation of the HDAC inhibitor belinostat and five major metabolites in human plasma

por Kiesel, Brian F., Parise, Robert A., Tjørnelund, Jette, Christensen, Mette K., Loza, Einars, Tawbi, Hussein, Chu, Edward, Kummar, Shivaani, Beumer, Jan H.
Publicado 2013

Retinal imaging with en face and cross-sectional optical coherence tomography delineates outer retinal changes in cancer-associated retinopathy secondary to Merkel cell carcinoma

por Mesiwala, Nisreen K, Shemonski, Nathan, Sandrian, Michelle G, Shelton, Ryan, Ishikawa, Hiroshi, Tawbi, Hussein A, Schuman, Joel S, Boppart, Stephen A, Labriola, Leanne T
Publicado en J Ophthalmic Inflamm Infect (2015)

The great debate at “Melanoma Bridge 2018”, Naples, December 1st, 2018

por Ascierto, Paolo A., Bruzzi, Paolo, Eggermont, Alexander, Hamid, Omid, Tawbi, Hussein A., van Akkooi, Alexander, Testori, Alessandro, Caracò, Corrado, Puzanov, Igor, Perrone, Francesco
Publicado en J Transl Med (2019)

PARP1 rs1805407 Increases Sensitivity to PARP1 Inhibitors in Cancer Cells Suggesting an Improved Therapeutic Strategy

por Abecassis, Irina, Sedgewick, Andrew J., Romkes, Marjorie, Buch, Shama, Nukui, Tomoko, Kapetanaki, Maria G., Vogt, Andreas, Kirkwood, John M., Benos, Panayiotis V., Tawbi, Hussein
Publicado en Sci Rep (2019)

Calcium-sensing receptor autoantibody-mediated hypoparathyroidism associated with immune checkpoint inhibitor therapy: diagnosis and long-term follow-up

por Dadu, Ramona, Rodgers, Theresa E, Trinh, Van A, Kemp, Elizabeth Helen, Cubb, Trisha D, Patel, Sapna, Simon, Julie M, Burton, Elizabeth M, Tawbi, Hussein
Publicado en J Immunother Cancer (2020)